Inventor · disambiguated record
Charles Baker-Glenn
Also filed as: BAKER-GLENN CHARLES · BAKER-GLENN CHARLES ANTHONY GRAHAM
27 granted patents·3 pending applications·187 citations·filing 2008–2021
95Inventor score
Top patents by PatentIndex Score
30 records- 0194US9212173B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·18 cites·3 claims
- 0293US8815882B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsBAKER-GLENN CHARLES·Filed 2011·Granted Aug 26, 2014·34 cites·22 claims
- 0393US8354420B2Aminopyrimidine derivatives as LRRK2 inhibitorsGENENTECH INC·Filed 2011·Granted Jan 15, 2013·27 cites·26 claims
- 0492US9212186B2Bicyclic pyrazole LRRK2 small molecule inhibitorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·11 cites·18 claims
- 0590US8791130B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Jul 29, 2014·18 cites·21 claims
- 0689US9145402B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Sep 29, 2015·15 cites·20 claims
- 0788US8802674B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 12, 2014·12 cites·15 claims
- 0888US8796296B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 5, 2014·14 cites·21 claims
- 0987US9199980B2CompoundsCHIESI FARMA SPA·Filed 2013·Granted Dec 1, 2015·5 cites·13 claims
- 1086US8809331B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 19, 2014·12 cites·5 claims
- 1184US9090606B2CompoundsCHIESI FARMA SPA·Filed 2013·Granted Jul 28, 2015·8 cites·14 claims
- 1281US9169245B2Inhibitors of PDE4 enzyme and antagonists of muscarinic M3 receptorCHIESI FARMA SPA·Filed 2013·Granted Oct 27, 2015·5 cites·16 claims
- 1380US9133185B2Heteroaryl derivativesCHIESI FARMA SPA·Filed 2014·Granted Sep 15, 2015·5 cites·15 claims
- 1468US9326976B2Carbamate derivativesCHIESI FARMA SPA·Filed 2015·Granted May 3, 2016·1 cites·13 claims
- 1568US9145409B2Benzhydryl derivativesCHIESI FARMA SPA·Filed 2014·Granted Sep 29, 2015·1 cites·17 claims
- 1657US2018016265A1Aminoester derivativesCHIESI FARM SPA·Filed 2017·Application pending·0 cites
- 1756US9809582B2Aminoester derivativesCHIESI FARM SPA·Filed 2016·Granted Nov 7, 2017·0 cites·17 claims
- 1854US8993757B2N-piperidin-4-yl derivativesHUISMAN INES·Filed 2012·Granted Mar 31, 2015·1 cites·8 claims
- 1950US10117860B2Aminoester derivativesCHIESI FARM SPA·Filed 2017·Granted Nov 6, 2018·0 cites·17 claims
- 2049US2023416233A1(aza)quinoline 4-amines derivatives as p2x3 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 2148US8202856B2Triazole oxadiazoles derivativesQUATTROPANI ANNA·Filed 2008·Granted Jun 19, 2012·0 cites·13 claims
- 2248US2024025880A1Amino quinazoline derivatives as p2x3 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 2347US9890151B23,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)- 2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitorsCHIESI FARM SPA·Filed 2014·Granted Feb 13, 2018·0 cites·8 claims
- 2446US10087176B23,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitorsCHIESI FARM SPA·Filed 2014·Granted Oct 2, 2018·0 cites·6 claims
- 2543US12466820B2Amino quinazoline derivatives as P2X3 inhibitorsCHIESI FARM SPA·Filed 2020·Granted Nov 11, 2025·0 cites·9 claims
- 2643US9763924B2Aminoester derivativesCHIESI FARM SPA·Filed 2015·Granted Sep 19, 2017·0 cites·16 claims
- 2736US8802663B2Pyrazole oxadiazole derivatives as S1P1 agonistsQUATTROPANI ANNA·Filed 2010·Granted Aug 12, 2014·0 cites·8 claims
- 2835US9636336B2Aminoester derivativesCHIESI FARM SPA·Filed 2016·Granted May 2, 2017·0 cites·17 claims
- 2934US9597323B2Aminoester derivativesCHIESI FARM SPA·Filed 2016·Granted Mar 21, 2017·0 cites·17 claims
- 3034US9029405B25-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate(SIP)receptorsBOMBRUN AGNES·Filed 2011·Granted May 12, 2015·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →